Metabolism: clinical and experimental最新文献

筛选
英文 中文
Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals GDF15与肝脏线粒体呼吸的关系取决于肥胖个体中纤维化的存在。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-09-13 DOI: 10.1016/j.metabol.2025.156391
Anna Giannakogeorgou , Sabine Kahl , Cesare Granata , Geronimo Heilmann , Lucia Mastrototaro , Bedair Dewidar , Pavel Bobrov , Irene Esposito , Aslihan Yavas , Sandra Trenkamp , Frank A. Granderath , Matthias Schlensak , Christos S. Mantzoros , Michael Roden , Patrick Schrauwen
{"title":"Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals","authors":"Anna Giannakogeorgou ,&nbsp;Sabine Kahl ,&nbsp;Cesare Granata ,&nbsp;Geronimo Heilmann ,&nbsp;Lucia Mastrototaro ,&nbsp;Bedair Dewidar ,&nbsp;Pavel Bobrov ,&nbsp;Irene Esposito ,&nbsp;Aslihan Yavas ,&nbsp;Sandra Trenkamp ,&nbsp;Frank A. Granderath ,&nbsp;Matthias Schlensak ,&nbsp;Christos S. Mantzoros ,&nbsp;Michael Roden ,&nbsp;Patrick Schrauwen","doi":"10.1016/j.metabol.2025.156391","DOIUrl":"10.1016/j.metabol.2025.156391","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Preclinical studies reported elevated growth differentiation factor 15 (GDF15) when mitochondrial function is reduced. In humans, metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) exhibit different hepatic mitochondrial adaptation. We hypothesized that circulating GDF15 differently correlates with hepatic mitochondrial respiration in obesity and/or MASLD/MASH.</div></div><div><h3>Methods</h3><div>Humans without (<em>n</em> = 20) and with biopsy-confirmed MASLD (n = 20) or MASH (n = 20) underwent hyperinsulinemic-euglycemic clamps to assess whole-body (M-value) and adipose-tissue (insulin-induced NEFA suppression) insulin sensitivity. Fasting serum GDF15 and glucagon were quantified by ELISA. Mitochondrial respiration was measured in liver obtained during bariatric surgery by high-resolution respirometry. Associations were assessed with Spearman's nonparametric correlation.</div></div><div><h3>Results</h3><div>Serum GDF15 correlated negatively with M-value (<em>r</em> = −0.35, <em>p</em> = 0.017) and NEFA suppression (<em>r</em> = −0.29, <em>p</em> = 0.046), but not with hepatic mitochondrial respiration across the whole cohort. However, correlations were found upon stratification into groups based on the presence (<em>n</em> = 37, age: 41 ± 2y, BMI: 49 ± 1 kg/m<sup>2</sup>) or absence of hepatic fibrosis (<em>n</em> = 23, 44 ± 2 years, BMI: 49 ± 1 kg/m<sup>2</sup>). In persons without fibrosis, GDF15 correlated positively with fatty acid oxidation-linked (F<sub>P</sub>; <em>r</em> = 0.35, <em>p</em> = 0.035) and maximal coupled (FNS<sub>P</sub>; <em>r</em> = 0.42, <em>p</em> = 0.010) mitochondrial respiration. Conversely, GDF15 correlated negatively with hepatic FN<sub>P</sub> in persons with fibrosis (<em>r</em> = −0.48, <em>p</em> = 0.022).</div></div><div><h3>Conclusions</h3><div>In humans with obesity, serum GDF15 correlates positively with hepatic mitochondrial respiration in persons without, but negatively in persons with hepatic fibrosis. Future studies are needed to investigate whether and how GDF15 affects hepatic mitochondrial respiration in a fibrosis-dependent manner and/or, conversely, how fibrosis might modulate hepatic GDF15 secretion through altered mitochondrial function.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"173 ","pages":"Article 156391"},"PeriodicalIF":11.9,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SerpinA3N in leptin-sensitive neurons is required for energy and glucose homeostasis and autonomic regulation 瘦素敏感神经元中的SerpinA3N是能量和葡萄糖稳态和自主调节所必需的。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-09-09 DOI: 10.1016/j.metabol.2025.156387
Deng Fu Guo , Zili Luo , Alexis Olson , Donald A. Morgan , Elizabeth A. Newell , Kamal Rahmouni
{"title":"SerpinA3N in leptin-sensitive neurons is required for energy and glucose homeostasis and autonomic regulation","authors":"Deng Fu Guo ,&nbsp;Zili Luo ,&nbsp;Alexis Olson ,&nbsp;Donald A. Morgan ,&nbsp;Elizabeth A. Newell ,&nbsp;Kamal Rahmouni","doi":"10.1016/j.metabol.2025.156387","DOIUrl":"10.1016/j.metabol.2025.156387","url":null,"abstract":"<div><h3>Aims</h3><div>SerpinA3N (Serpin peptidase inhibitor clade A member 3) is a serine protease inhibitor upregulated in the hypothalamus by leptin and obesity, yet its role in physiological regulation remains poorly understood. This study aims to elucidate the role of hypothalamic SerpinA3N in regulation of energy balance, glucose homeostasis, and autonomic and cardiovascular functions.</div></div><div><h3>Methods and results</h3><div>Immunostaining revealed that SerpinA3N is primarily expressed in neurons, including those expressing the leptin receptor (LepRb). Targeted deletion of SerpinA3N in LepRb neurons reduced body weight and adiposity and improved insulin sensitivity in female mice. SerpinA3N deficiency also enhanced leptin sensitivity, evidenced by amplified leptin-induced anorexia, weight loss, and LepRb signaling in the hypothalamic arcuate nucleus. Upon exposure to an obesogenic diet, mice lacking SerpinA3N in LepRb neurons exhibited attenuated weight gain, hepatic lipid accumulation and microgliosis. Notably, SerpinA3N deletion in LepRb neurons impaired baroreflex sensitivity and elevated renal sympathetic nerve activity, with dietary obesity further exacerbating sympathetic tone.</div></div><div><h3>Conclusions</h3><div>These findings identify neuronal SerpinA3N as a key regulator of energy balance, leptin and insulin sensitivity, and autonomic function.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"173 ","pages":"Article 156387"},"PeriodicalIF":11.9,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145040726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedside 调节代谢以改善CAR细胞疗法的治疗效果:从实验到临床。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-08-28 DOI: 10.1016/j.metabol.2025.156375
Dengxiong Li , Jie Wang , Ruicheng Wu , Qingxin Yu , Fanglin Shao , Dilinaer Wusiman , Zhipeng Wang , Zhouting Tuo , Luxia Ye , Yiqing Guo , Koo Han Yoo , Zhihong Liu , William C. Cho , Dechao Feng
{"title":"Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedside","authors":"Dengxiong Li ,&nbsp;Jie Wang ,&nbsp;Ruicheng Wu ,&nbsp;Qingxin Yu ,&nbsp;Fanglin Shao ,&nbsp;Dilinaer Wusiman ,&nbsp;Zhipeng Wang ,&nbsp;Zhouting Tuo ,&nbsp;Luxia Ye ,&nbsp;Yiqing Guo ,&nbsp;Koo Han Yoo ,&nbsp;Zhihong Liu ,&nbsp;William C. Cho ,&nbsp;Dechao Feng","doi":"10.1016/j.metabol.2025.156375","DOIUrl":"10.1016/j.metabol.2025.156375","url":null,"abstract":"<div><div>Chimeric antigen receptor (CAR) cell therapies have emerged as a groundbreaking approach in cancer treatment, offering new hope for patients with refractory tumors. Despite their success, the therapeutic efficacy of CAR cell therapies is often undermined by metabolic factors within the tumor microenvironment (TME), which impede CAR cell function and lead to treatment resistance. Current literature has not fully explored how these metabolic processes contribute to CAR cell therapy failure, particularly in the context of solid tumors, where the TME presents unique challenges. Addressing this gap is crucial for enhancing the effectiveness of CAR cell therapies across a broader range of cancers. Here, we review the latest research on the metabolic mechanisms that influence CAR cell therapy outcomes, from preclinical studies to clinical applications. We conducted a comprehensive analysis of studies from PubMed and Web of Science, focusing on how various metabolic processes—such as hypoxia, immune cytokine signaling, glycolysis, adenine metabolism, cellular senescence, lactic acid increment, and cholesterol metabolism—affect CAR cell functions, including cytotoxicity, proliferation, stemness, and activation. Additionally, we examine how interactions between CAR cells and other components of the TME, such as tumor cells, stromal cells, and the extracellular matrix, contribute to an immune-suppressive environment that diminishes CAR cell efficacy. We also discuss potential strategies for overcoming these metabolic barriers, including the development of CAR cells with enhanced metabolic regulation, gene expression modulation, and the combination of CAR cell therapy with existing pharmacological treatments. Our findings underscore the critical role of metabolism in shaping the anti-tumor efficacy of CAR cell therapies in both hematologic and solid tumors. By targeting metabolic pathways within the TME, it is possible to enhance CAR cell infiltration, function, and persistence, thereby overcoming resistance and improving therapeutic outcomes. This approach not only addresses a key limitation in current CAR cell therapies but also paves the way for more effective cancer treatments in the future.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"173 ","pages":"Article 156375"},"PeriodicalIF":11.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144961527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1” [Metabolism, Volume 163 (2025), Article Number 156087] “β细胞功能受损和葡萄糖耐量受损的人类受试者具有更高水平的胰岛内完整GLP-1”的勘误表[Metabolism, Volume 163(2025),文章号156087]
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-08-13 DOI: 10.1016/j.metabol.2025.156372
Teresa Mezza , Nicolai J. Wewer Albrechtsen , Gianfranco Di Giuseppe , Pietro Manuel Ferraro , Laura Soldovieri , Gea Ciccarelli , Michela Brunetti , Giuseppe Quero , Sergio Alfieri , Enrico Celestino Nista , Antonio Gasbarrini , Vincenzo Tondolo , Andrea Mari , Alfredo Pontecorvi , Andrea Giaccari , Jens J. Holst
{"title":"Corrigendum to “Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1” [Metabolism, Volume 163 (2025), Article Number 156087]","authors":"Teresa Mezza ,&nbsp;Nicolai J. Wewer Albrechtsen ,&nbsp;Gianfranco Di Giuseppe ,&nbsp;Pietro Manuel Ferraro ,&nbsp;Laura Soldovieri ,&nbsp;Gea Ciccarelli ,&nbsp;Michela Brunetti ,&nbsp;Giuseppe Quero ,&nbsp;Sergio Alfieri ,&nbsp;Enrico Celestino Nista ,&nbsp;Antonio Gasbarrini ,&nbsp;Vincenzo Tondolo ,&nbsp;Andrea Mari ,&nbsp;Alfredo Pontecorvi ,&nbsp;Andrea Giaccari ,&nbsp;Jens J. Holst","doi":"10.1016/j.metabol.2025.156372","DOIUrl":"10.1016/j.metabol.2025.156372","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"172 ","pages":"Article 156372"},"PeriodicalIF":11.9,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144988201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Syndecan-1 regulates lipid metabolism and mitigates fibrosis during the transition from acute kidney injury to chronic kidney disease Syndecan-1调节脂质代谢,减轻急性肾损伤向慢性肾病转变过程中的纤维化。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-08-07 DOI: 10.1016/j.metabol.2025.156374
Daoqi Shen , Liyu Lin , Yiqi Su , Ying Huang , Yaqiong Wang , Jiarui Xu , Wuhua Jiang , Zhen Zhang , Xiaoqiang Ding , Xialian Xu
{"title":"Syndecan-1 regulates lipid metabolism and mitigates fibrosis during the transition from acute kidney injury to chronic kidney disease","authors":"Daoqi Shen ,&nbsp;Liyu Lin ,&nbsp;Yiqi Su ,&nbsp;Ying Huang ,&nbsp;Yaqiong Wang ,&nbsp;Jiarui Xu ,&nbsp;Wuhua Jiang ,&nbsp;Zhen Zhang ,&nbsp;Xiaoqiang Ding ,&nbsp;Xialian Xu","doi":"10.1016/j.metabol.2025.156374","DOIUrl":"10.1016/j.metabol.2025.156374","url":null,"abstract":"<div><h3>Background</h3><div>The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) is characterized by persistent renal fibrosis, in which abnormal lipid metabolism plays a crucial role. Syndecan-1 (SDC-1) has been implicated in various tissue remodeling processes; however, its role in lipid metabolism and fibrosis during the progression from AKI to CKD is not well understood.</div></div><div><h3>Methods</h3><div>This study used a murine model of unilateral ischemia-reperfusion-induced AKI-to-CKD progression for in vivo analysis and employed transforming growth factor-beta (TGF-β)-induced fibrosis in Human Kidney-2 cells and primary mouse tubular epithelial cells for in vitro studies. The tubule-specific knockout and overexpression of SDC-1 mice were utilized to investigate kidney fibrosis and lipid metabolism.</div></div><div><h3>Results</h3><div>Following unilateral ischemia-reperfusion and TGF-β stimulation, SDC-1 expression was significantly reduced, exacerbating renal fibrosis. Notably, SDC-1 deficiency led to lipid accumulation in the kidneys, while its overexpression alleviated lipid overload and improved metabolic parameters. Furthermore, SDC-1 played a crucial role in regulating fatty acid-binding protein 7 (FABP7), and its absence resulted in increased FABP7 levels. Inhibition of FABP7 not only reduced fibrosis but also restored carnitine palmitoyltransferase 1α expression, which suggests that the SDC-1/FABP7 axis is critical for maintaining lipid homeostasis and mitigating fibrosis in the kidney.</div></div><div><h3>Conclusion</h3><div>These findings underscore the importance of SDC-1 in lipid metabolism and suggest that targeting lipid metabolic pathways may represent therapeutic strategies that can slow the progression of AKI to CKD.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"172 ","pages":"Article 156374"},"PeriodicalIF":11.9,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144812129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symphony of regulated cell death: Unveiling therapeutic horizons in sarcopenia 调控细胞死亡交响曲:揭示肌肉减少症的治疗前景
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-07-31 DOI: 10.1016/j.metabol.2025.156359
Jie Peng , Mi Zou , Qianmingyue Zhang , Dongcan Liu , Shuanghong Chen , Ruiying Fang , Yuan Gao , Xiaohua Yan , Liang Hao
{"title":"Symphony of regulated cell death: Unveiling therapeutic horizons in sarcopenia","authors":"Jie Peng ,&nbsp;Mi Zou ,&nbsp;Qianmingyue Zhang ,&nbsp;Dongcan Liu ,&nbsp;Shuanghong Chen ,&nbsp;Ruiying Fang ,&nbsp;Yuan Gao ,&nbsp;Xiaohua Yan ,&nbsp;Liang Hao","doi":"10.1016/j.metabol.2025.156359","DOIUrl":"10.1016/j.metabol.2025.156359","url":null,"abstract":"<div><div>Sarcopenia is a progressive musculoskeletal condition associated with aging, marked by a decline in muscle mass, strength, and performance. This condition not only compromises functional independence in older individuals but also contributes to escalating healthcare and economic burdens. Although the underlying mechanisms are complex and multifaceted, recent discoveries have emphasized the regulatory influence of multiple forms of programmed cell death—including apoptosis, ferroptosis, necroptosis, and pyroptosis—on skeletal muscle degeneration. These cell death pathways contribute to key pathological features such as muscle fiber loss, proteostasis imbalance, neuromuscular dysfunction, mitochondrial deficits, and persistent inflammation. This review synthesizes current understanding of the molecular underpinnings of regulated cell death (RCD) in sarcopenia and discusses emerging therapeutic interventions aimed at modulating these pathways. These include pharmacological agents (e.g., ferroptosis inhibitors, polyphenols), structured exercise programs (notably resistance), targeted nutritional support (e.g., amino acids, vitamin D), cell-based therapies, and gene-targeted strategies. Despite growing evidence supporting RCD as a viable therapeutic target, the interplay among different cell death modalities and the translation of mechanistic insights into clinical practice remain insufficiently understood. Advancing sarcopenia treatment will require integrated multi-omics analyses, identification of predictive biomarkers, and rigorously designed clinical studies to support personalized and effective therapeutic approaches.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"172 ","pages":"Article 156359"},"PeriodicalIF":11.9,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144756831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The intersection of exercise, nitric oxide, and metabolism: Unraveling the role of eNOS in skeletal muscle and beyond 运动、一氧化氮和代谢的交叉:揭示eNOS在骨骼肌及其他部位的作用。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-07-30 DOI: 10.1016/j.metabol.2025.156360
Pierre-Anne R. Laird , Rebecca M. Wall , Siobhan M. Craige
{"title":"The intersection of exercise, nitric oxide, and metabolism: Unraveling the role of eNOS in skeletal muscle and beyond","authors":"Pierre-Anne R. Laird ,&nbsp;Rebecca M. Wall ,&nbsp;Siobhan M. Craige","doi":"10.1016/j.metabol.2025.156360","DOIUrl":"10.1016/j.metabol.2025.156360","url":null,"abstract":"<div><div>Exercise protects against several diseases including cardiometabolic disorders. However, the molecular mechanisms driving these adaptations remain incompletely defined. Endothelial nitric oxide synthase (eNOS), a key source of nitric oxide (NO), is implicated in regulating glucose uptake, fatty acid metabolism, and mitochondrial remodeling in response to exercise. eNOS is expressed in both endothelial and non-endothelial cells and its effects on metabolism are multifaceted. Notably, eNOS is highly expressed in endothelial cells which are ubiquitous throughout all organ systems allowing them to closely integrate with surrounding cell types. This unique feature of the endothelium enables eNOS to influence both local microenvironments and signaling across organ systems. This review summarizes current findings on the role of eNOS-derived NO in exercise metabolism. Evidence suggests eNOS contributes to improved metabolic flexibility, enhanced mitochondrial function, and tissue crosstalk. However, data across experimental models remain mixed, with both supportive and conflicting results. Collectively, the literature indicates that eNOS plays a central, though context-dependent, role in facilitating exercise-induced metabolic benefits. Identifying the specific mechanisms and tissue contributions of eNOS activity remains an important area for future investigation, with potential relevance to metabolic disease prevention and treatment.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"173 ","pages":"Article 156360"},"PeriodicalIF":11.9,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144765087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis 7个民族65个综合征基因和8个单基因肥胖基因的自然选择特征不支持节俭基因型假说。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-07-28 DOI: 10.1016/j.metabol.2025.156353
Sandra El Kouche , David Meyre
{"title":"Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis","authors":"Sandra El Kouche ,&nbsp;David Meyre","doi":"10.1016/j.metabol.2025.156353","DOIUrl":"10.1016/j.metabol.2025.156353","url":null,"abstract":"<div><h3>Background</h3><div>The “thrifty genotype hypothesis” states that gene variants promoting efficient fat deposition may have been advantaged by natural selection to allow human survival during famine. Nowadays, such genes are rendered detrimental by progress as they promote fat deposition in preparation for a famine that never comes, resulting in widespread obesity. Obesity is genetically heterogeneous, with a continuum between very rare syndromic, rare monogenic, and common polygenic forms of obesity. The identification of natural selection signatures has been largely restricted to polygenic obesity-susceptibility variants, and this approach has failed to validate the thrifty genotype hypothesis. However, polygenic variants may not be as relevant as monogenic mutations, characterized by strong phenotypic effects on body mass index variation and obesity risk, in detecting significant signatures of natural selection.</div></div><div><h3>Methods</h3><div>We investigated the patterns of natural selection of 65 syndromic and 8 monogenic obesity genes in the gnomAD multiethnic population (N = 807,162).</div></div><div><h3>Results</h3><div>Our data suggest that most dominant syndromic obesity genes display negative signatures of natural selection (i.e., deleterious alleles are selectively purged from the population). In contrast, monogenic obesity genes exhibit neither negative nor positive patterns of natural selection. Our findings do not support the thrifty genotype hypothesis for syndromic and monogenic hyperphagic obesity in 7 ethnic groups.</div></div><div><h3>Conclusion</h3><div>Our work highlights the evolutionary mechanisms that have shaped the modern ethnic distribution of monogenic and syndromic obesity mutations, why some individuals are susceptible to obesity and have a profound impact on therapeutic strategies for managing chronic diseases.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"171 ","pages":"Article 156353"},"PeriodicalIF":11.9,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144743135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactiplantibacillus plantarum strain 84-3-derived l-glutamine ameliorates glucose homeostasis via AMPK/PPARγ signaling pathway activation in type 2 diabetes 植物乳杆菌菌株84-3衍生的l-谷氨酰胺通过激活AMPK/PPARγ信号通路改善2型糖尿病患者的葡萄糖稳态
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-07-28 DOI: 10.1016/j.metabol.2025.156357
Tingting Liang , Tong Jiang , Zhuang Liang , Ya Chen , Tong Chen , Bo Dong , Xinqiang Xie , Bing Gu , Qingping Wu
{"title":"Lactiplantibacillus plantarum strain 84-3-derived l-glutamine ameliorates glucose homeostasis via AMPK/PPARγ signaling pathway activation in type 2 diabetes","authors":"Tingting Liang ,&nbsp;Tong Jiang ,&nbsp;Zhuang Liang ,&nbsp;Ya Chen ,&nbsp;Tong Chen ,&nbsp;Bo Dong ,&nbsp;Xinqiang Xie ,&nbsp;Bing Gu ,&nbsp;Qingping Wu","doi":"10.1016/j.metabol.2025.156357","DOIUrl":"10.1016/j.metabol.2025.156357","url":null,"abstract":"<div><h3>Background</h3><div>Gut microbiota and their metabolites play an essential role in type 2 diabetes (T2D). However, contributions of individual bacterial strains and their metabolites to T2D pathogenesis remain poorly understood. We investigated T2D regulation by <em>Lactobacillus</em> in various animal models to understand its therapeutic effects.</div></div><div><h3>Methods and results</h3><div>We performed a case-control study of Chinese adults using metabolome profiling and identified an inverse correlation between <span>l</span>-glutamine and T2D serum concentrations. The <em>glnA</em> and <em>GLUL</em> genes encoding glutamine synthetase (GS) in <em>L. plantarum</em> 84–3 were also identified. <em>L. plantarum</em> 84–3 treatment significantly decreased serum inflammation and improved metabolic phenotypes in streptozotocin- or tetraoxypyrimidine-induced T2D rats, including blood glucose, glucose tolerance, insulin resistance, and lipids. We confirmed elevated serum <span>l</span>-glutamine levels in the <em>L. plantarum</em> 84–3 group. RNA sequencing analysis demonstrated that <em>L. plantarum</em> 84–3-derived <span>l</span>-glutamine is a vital bioactive molecule, improving glucose homeostasis by activating the liver AMPK/PPAR signaling pathway and ameliorating T2D. We conducted co-culture fermentation experiments <em>in vitro</em> and <em>in vivo</em>, and metagenomic and metabolomic analyses revealed that resistance starch combined with <em>L. plantarum</em> 84–3 significantly enriched of <em>Lactobacillus</em> abundance and increased the <span>l</span>-glutamine level, affecting of alanine, aspartate, and glutamate metabolism pathways, which was confirmed <em>in vivo</em> in rats. The reduced <em>L. plantarum</em> and <span>l</span>-glutamine levels were validated in a human T2D cohort.</div></div><div><h3>Conclusions</h3><div>These findings revealed a novel therapeutic effect of <em>L. plantarum</em> in alleviating T2D-related glucose homeostasis by increasing circulating <span>l</span>-glutamine, which suggests viable preventive and therapeutic strategies for metabolic disorders.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"172 ","pages":"Article 156357"},"PeriodicalIF":11.9,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144753812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies 揭示线粒体sirtuins在衰老相关疾病中的作用:从机制见解到治疗策略。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-07-24 DOI: 10.1016/j.metabol.2025.156356
Yanyan Cao , Yan Wang , Na Zhao , Ziyue Yuan , Lan Zhang , Peng Jin
{"title":"Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies","authors":"Yanyan Cao ,&nbsp;Yan Wang ,&nbsp;Na Zhao ,&nbsp;Ziyue Yuan ,&nbsp;Lan Zhang ,&nbsp;Peng Jin","doi":"10.1016/j.metabol.2025.156356","DOIUrl":"10.1016/j.metabol.2025.156356","url":null,"abstract":"<div><div>Mitochondrial sirtuins, including SIRT3, SIRT4, and SIRT5, play pivotal roles in maintaining mitochondrial homeostasis by regulating oxidative phosphorylation, energy metabolism, and redox balance. Dysregulation of these enzymes is closely associated with the pathogenesis of aging-related diseases such as neurodegenerative diseases, metabolic diseases, and cardiovascular diseases. SIRT3 has been the most extensively studied, demonstrating protective effects against oxidative stress and metabolic dysregulation. In contrast, while SIRT4 and SIRT5 are less characterized, they are critical for the regulation of insulin sensitivity, nitrogen metabolism, and mitochondrial function. This review focuses on the involvement of mitochondrial sirtuins in modulating cellular metabolism, redox balance, and mitochondrial homeostasis, highlighting their roles in the development and progression of aging-related diseases. Furthermore, we provide an overview of small-molecule modulators targeting mitochondrial sirtuins, which aim to restore cellular function, attenuate aging processes, and offer novel therapeutic strategies for treating aging-related diseases.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"172 ","pages":"Article 156356"},"PeriodicalIF":11.9,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信